Evaluation of Syncope,Its Diagnosis, Treatment, Outcome and Prognosis (E-STOP)

This study has been completed.
Transoma Medical
Information provided by:
St. Luke's-Roosevelt Hospital Center
ClinicalTrials.gov Identifier:
First received: October 1, 2008
Last updated: July 1, 2010
Last verified: July 2010
The investigators want to look at how patients admitted after passing out (syncope) or nearly passing out (pre-syncope) do after going home and how many of them remain free of symptoms of syncope or pre-syncope.


Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: E-STOP Registry: A Registry for the Evaluation of Syncope,Its Diagnosis, Treatment, Outcome and Prognosis Using Our SELF-Pathway

Resource links provided by NLM:

Further study details as provided by St. Luke's-Roosevelt Hospital Center:

Estimated Enrollment: 540
Study Start Date: June 2008
Study Completion Date: July 2010
Primary Completion Date: July 2009 (Final data collection date for primary outcome measure)


Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
All patietns admitted to the adult medicine service at St. Luke's-Roosevelt Hospital with diagnossi of syncope or near syncope

Inclusion Criteria:

  • All adult patients (age 18 or older) admitted with syncope or near-syncope

Exclusion Criteria:

  • Patients who do not speak/read the language of the consent form
  • Prisoners
  • Patients who are of altered mental status or had head trauma
  • Refusal or inability to sign consent
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00764985

United States, New York
St. Luke's-Roosevelt Hospital Center
New York, New York, United States, 10025
Sponsors and Collaborators
St. Luke's-Roosevelt Hospital Center
Transoma Medical
  More Information

Responsible Party: Suneet Mittal, St. Luke's-Roosevelt Hospitals
ClinicalTrials.gov Identifier: NCT00764985     History of Changes
Other Study ID Numbers: ESTOP-08-024 
Study First Received: October 1, 2008
Last Updated: July 1, 2010
Health Authority: United States: Institutional Review Board

Keywords provided by St. Luke's-Roosevelt Hospital Center:

Additional relevant MeSH terms:
Consciousness Disorders
Nervous System Diseases
Neurobehavioral Manifestations
Neurologic Manifestations
Signs and Symptoms

ClinicalTrials.gov processed this record on May 30, 2016